Frontier Biotechnologies

688221 · SSE STAR Market

Public Market Listing

688221SSE STAR Market

SSE STAR Market primary exchange listing

Live quotes, historical charts, and market capitalization for Frontier Biotechnologies are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Albuvirtide(Aikening)
Phase 3
HIV gp41Peptide
HIV
3BNC117No recent activity
Phase 2
HIV envelopeMonoclonal antibody
HIV

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (3 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$17M$20M—$37Mreport ↗
View 2 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$18M$19M—$28Mreport ↗
2023-FY$16M———report ↗